Cassio Marinho Campelo*
Volume2-Issue3
Dates: Received: 2021-03-16 | Accepted: 2021-03-30 | Published: 2021-03-31
Pages: 216-217
Abstract
The complement system is one of the host’s primary defence mechanisms against pathogens. Its activation involves proteolytic cascades of enzymatic reactions that result in products with effector functions and recognition of molecules on the surface of microorganisms [1,2].
FullText HTML
FullText PDF
DOI: 10.37871/jbres1214
Certificate of Publication
Copyright
© 2021 Campelo CM. Distributed under Creative Commons CC-BY 4.0 
How to cite this article
Campelo CM. Importance the Type 1 (CR1) and Type 3 (CR3) Complement Receptors in the Infectious Disease. J Biomed ResEnviron Sci. 2021 Mar 31; 2(3): 216-217. doi: 10.37871/jbres1214, Article ID: jbres1214
Subject area(s)
References
- Merle NS, Church SE, Fremeaux-Bacchi V, Roumenina LT. Complement System Part I - Molecular Mechanisms of Activation and Regulation. Front Immunol. 2015 Jun 2;6:262. doi: 10.3389/fimmu.2015.00262. PMID: 26082779; PMCID: PMC4451739.
- Bullard DC. The complement factsbook (second edition). 2018;435-450 doi: 10.1016/B978-0-12-810420-0.00041-9.
- Ahmadzai MM, Broadbent D, Occhiuto C, Yang C, Das R, Subramanian H. Canonical and Noncanonical Signaling Roles of β-Arrestins in Inflammation and Immunity. Adv Immunol. 2017;136:279-313. doi: 10.1016/bs.ai.2017.05.004. Epub 2017 Jun 17. PMID: 28950948.
- Ricklin D, Hajishengallis G, Yang K, Lambris JD. Complement: a key system for immune surveillance and homeostasis. Nat Immunol. 2010 Sep;11(9):785-97. doi: 10.1038/ni.1923. Epub 2010 Aug 19. PMID: 20720586; PMCID: PMC2924908.
- Ross GD, Yount WJ, Walport MJ, Winfield JB, Parker CJ, Fuller CR, Taylor RP, Myones BL, Lachmann PJ. Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation. J Immunol. 1985 Sep;135(3):2005-14. PMID: 4020137.
- Kumar A, Malaviya AN, Srivastava LM. Lowered expression of C3b receptor (CR1) on erythrocytes of rheumatoid arthritis patients. Immunobiology. 1994 Aug;191(1):9-20. doi: 10.1016/S0171-2985(11)80264-0. PMID: 7806259.
- Mouhoub A, Delibrias CC, Fischer E, Boyer V, Kazatchkine MD. Ligation of CR1 (C3b receptor, CD35) on CD4+ T lymphocytes enhances viral replication in HIV-infected cells. Clin Exp Immunol. 1996 Nov;106(2):297-303. doi: 10.1046/j.1365-2249.1996.d01-844.x. PMID: 8918576; PMCID: PMC2200595.
- Stoute JA. Complement receptor 1 and malaria. Cell Microbiol. 2011 Oct;13(10):1441-50. doi: 10.1111/j.1462-5822.2011.01648.x. Epub 2011 Aug 24. PMID: 21790941.
- Ueno N, Wilson ME. Receptor-mediated phagocytosis of Leishmania: implications for intracellular survival. Trends Parasitol. 2012 Aug;28(8):335-44. doi: 10.1016/j.pt.2012.05.002. Epub 2012 Jun 21. PMID: 22726697; PMCID: PMC3399048.
- Campelo CM, Pinheiro IC, de Melo Tavares B, Alves de Lima Henn G, Fernandes C, Albuquerque-Pinto LC, Carneiro Câmara LM. Modulation in the expression of type 1 (CR1/CD35) and type 3 (CR3/CD11b) complement receptors on leukocytes from patients with Visceral leishmaniasis. Exp Parasitol. 2020 Nov;218:107970. doi: 10.1016/j.exppara.2020.107970. Epub 2020 Aug 21. PMID: 32828829.
